查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1945483

2026年全球血脂检查市场报告

Lipid Panel Testing Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，血脂检测市场发展迅速，预计将从2025年的116.1亿美元成长到2026年的126.1亿美元，复合年增长率达8.6%。过去几年的成长可归因于多种因素，例如心血管疾病盛行率的上升、常规健康检查计画的推广、人们对胆固醇管理意识提升、自动化检测设备的引入以及诊断服务可及性的改善。

预计未来几年，血脂检查市场将维持强劲成长，到2030年市场规模将达到177.9亿美元，复合年增长率（CAGR）为9.0%。预测期内的成长要素包括：对预防性医疗保健的日益重视、对家庭诊断需求的成长、数位健康平台的整合、人工智慧辅助诊断解读的日益普及以及人群健康筛检计画的扩展。预测期内的主要趋势包括：照护现场血脂检测的普及、自动化血脂分析仪的使用增加、对预防性心血管筛检的需求增长、家用血脂检测套组的普及以及对早期风险评估的日益重视。

预计心血管疾病和糖尿病的盛行率上升将推动血脂检查市场的成长。心血管疾病是一组影响心臟和血管的疾病，而糖尿病是一种影响胰岛素分泌并导致血糖值升高的代谢紊乱疾病，这两种疾病都在推动血脂检查的需求。这种诊断工具对于识别有心血管疾病风险或已患有心血管疾病的人至关重要。它还有助于监测治疗效果，使医疗保健提供者能够制定个人化的治疗方案，以达到目标血脂水平并降低患病风险。例如，根据美国心臟学会（总部位于美国的非营利医疗组织）2025年9月的数据，预计2023年全球因心血管疾病死亡的人数将达到约1,920万人。因此，心血管疾病和糖尿病盛行率的不断上升预计将推动血脂检查市场的成长。

血脂检查市场的主要参与者正致力于开发先进的诊断解决方案，包括基于脂蛋白(a)的检测，以增强心血管风险评估。基于脂蛋白(a)的检测是一种诊断测试，用于测量血液中脂蛋白(a)的水平，使临床医生能够识别心血管疾病高风险族群，并制定更个人化的治疗方案。例如，2024年5月，总部位于瑞士的生物技术和诊断公司罗氏(F. Hoffmann-La Roche AG)在获得美国食品药物管理局(FDA)的突破性医疗设备认定后，推出了Tina-quant Lp(a) RxDx检测。此检测可量化每公升血液中脂蛋白(a)颗粒的数量，为心血管风险评估提供标准化的、具有临床意义的生物标记。此检测旨在与罗氏现有的血清工作站系统和cobas平台集成，从而支持有关降低脂蛋白(a)治疗的知情临床决策，提高诊断准确性，并促进个人化血脂管理方法的更广泛应用。

目录

第一章执行摘要

第二章 市场特征

  • 市场定义和范围
  • 市场区隔
  • 主要产品和服务概述
  • 全球血脂检查市场：吸引力评分及分析
  • 成长潜力分析、竞争评估、策略契合度评估、风险状况评估

第三章 市场供应链分析

  • 供应链与生态系概述
  • 主要原料、资源和供应商清单
  • 主要经销商和通路合作伙伴名单
  • 主要最终用户列表

第四章 全球市场趋势与策略

  • 关键技术和未来趋势
    • 生物技术、基因组学和精准医学
    • 数位化、云端运算、巨量资料、网路安全
    • 物联网、智慧基础设施和互联生态系统
    • 人工智慧（AI）和自主人工智慧
    • 工业4.0和智慧製造
  • 主要趋势
    • 照护现场血脂检测的普及率不断提高
    • 自动血脂分析仪的使用日益增多
    • 对预防性心血管筛检的需求日益增长
    • 扩大家用血脂检测套组的使用范围
    • 越来越重视早期风险评估

第五章 终端用户产业市场分析

  • 医院
  • 诊断诊所
  • 病理检查室
  • 专科部门和医生诊所
  • 门诊手术中心

第六章 市场：宏观经济情景，包括利率、通货膨胀、地缘政治、贸易战和关税的影响、关税战和贸易保护主义对供应链的影响，以及新冠疫情对市场的影响

第七章 全球策略分析架构、目前市场规模、市场对比及成长率分析

  • 全球血脂检查市场：PESTEL 分析（政治、社会、技术、环境、法律因素、驱动因素和限制因素）
  • 全球血脂检查市场规模、比较及成长率分析
  • 全球血脂检查市场表现：规模与成长，2020-2025年
  • 全球血脂检查市场预测：规模与成长，2025-2030年，2035年预测

第八章 全球潜在市场规模（TAM）

第九章 市场细分

  • 按产品和服务分类
  • 设备、套件和服务
  • 透过处方模式
  • 处方笺和非处方药检测
  • 透过使用
  • 高血脂症、高三酸甘油脂血症、遗传性高胆固醇症、低脂蛋白血症、坦齐尔氏症、动脉粥状硬化及其他适应症
  • 最终用户
  • 医院、专科诊所和医生诊所、病理检查室、诊断诊所、参考检查室、学术和研究机构以及其他最终用户
  • 按类型细分：设备
  • 自动化分析仪、就地检验设备、光强度
  • 按类型细分：套装
  • 胆固醇、高密度脂蛋白和低密度脂蛋白检测试剂盒，三酸甘油酯检测套组
  • 按类型细分：服务
  • 检测服务、诊断服务、健康体检服务

第十章 区域与国家分析

  • 全球血脂检查市场：依地区、绩效及预测划分，2020-2025年、2025-2030年预测、2035年预测
  • 全球血脂检查市场：依国家、绩效及预测划分，2020-2025年、2025-2030年预测、2035年预测

第十一章 亚太市场

第十二章：中国市场

第十三章 印度市场

第十四章 日本市场

第十五章：澳洲市场

第十六章 印尼市场

第十七章 韩国市场

第十八章 台湾市场

第十九章 东南亚市场

第二十章：西欧市场

第21章英国市场

第22章 德国市场

第23章：法国市场

第24章：义大利市场

第25章：西班牙市场

第26章 东欧市场

第27章：俄罗斯市场

第28章 北美市场

第29章：美国市场

第30章：加拿大市场

第31章 南美洲市场

第32章：巴西市场

第33章 中东市场

第34章：非洲市场

第35章 市场监理与投资环境

第36章：竞争格局与公司概况

  • 血脂检查市场：竞争格局及市场占有率（2024年）
  • 血脂检查市场：公司评估矩阵
  • 血脂检查市场：公司概况
    • Abbott Laboratories
    • Beckman Coulter Inc.
    • F. Hoffmann-La Roche Ltd.
    • Randox Laboratories Ltd.
    • Thermo Fisher Scientific Inc.

第37章：其他领先和创新企业

  • PTS Diagnostics, Quest Diagnostics Incorporated, Alere Inc., Boston Heart Diagnostics Corporation, Eurofins Scientific SE, Spark Diagnostics Pvt Ltd., Everlywell Inc., Horiba ABX SAS, Siemens Healthcare GmbH, Nova Biomedical Corporation, Bio-Rad Laboratories Inc., Danaher Corporation, DiaSorin SpA, EKF Diagnostics Holdings plc, Ortho Clinical Diagnostics LLC

第38章 全球市场竞争基准分析与仪錶板

第39章 重大併购

第四十章：高潜力市场国家、细分市场与策略

  • 2030年血脂检查市场：提供新机会的国家
  • 2030年血脂检查市场：新兴细分市场机会
  • 2030年血脂检查市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第41章附录

简介目录
Product Code: ME4MLPTA01_G26Q1

Lipid panel testing refers to a blood test that measures the levels of various lipids or fats in the blood. This test is commonly used to assess an individual's risk of developing cardiovascular disease.

The main products and services related to lipid panel testing include devices, kits, and services. Devices, such as analyzer machines, are the equipment used to perform lipid panel testing. The various prescription modes for lipid panel testing include prescription-based testing and over-the-counter (OTC) based testing. Lipid panel testing is applied in various conditions such as hyperlipidemia, hypertriglyceridemia, familial hypercholesterolemia, hypo-lipoproteinamia, Tangier disease, atherosclerosis, and others. The diverse end users of lipid panel testing products and services encompass hospitals, specialty clinics and physician offices, pathology laboratories, diagnostic clinics, ambulatory surgical centers, reference laboratories, academic and research institutes, and others.

Tariffs are impacting the lipid panel testing market by increasing costs of imported diagnostic reagents, testing kits, automated analyzers, and electronic components used in laboratory and point-of-care systems. Diagnostic laboratories and healthcare providers in North America and Europe are most affected due to reliance on imported consumables and devices, while Asia-Pacific faces cost pressures on test kit manufacturing and exports. These tariffs are raising testing costs and affecting procurement cycles. However, they are also encouraging local production of diagnostic kits, regional reagent manufacturing, and supply chain diversification.

The lipid panel testing market research report is one of a series of new reports from The Business Research Company that provides lipid panel testing market statistics, including lipid panel testing industry global market size, regional shares, competitors with a lipid panel testing market share, detailed lipid panel testing market segments, market trends and opportunities, and any further data you may need to thrive in the lipid panel testing industry. This lipid panel testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The lipid panel testing market size has grown strongly in recent years. It will grow from $11.61 billion in 2025 to $12.61 billion in 2026 at a compound annual growth rate (CAGR) of 8.6%. The growth in the historic period can be attributed to increasing prevalence of cardiovascular diseases, expansion of routine health screening programs, growing awareness of cholesterol management, adoption of automated laboratory diagnostics, improved access to diagnostic services.

The lipid panel testing market size is expected to see strong growth in the next few years. It will grow to $17.79 billion in 2030 at a compound annual growth rate (CAGR) of 9.0%. The growth in the forecast period can be attributed to increasing focus on preventive healthcare, rising demand for home diagnostics, integration of digital health platforms, growing use of AI-assisted diagnostic interpretation, expansion of population health screening initiatives. Major trends in the forecast period include increasing adoption of point-of-care lipid testing, rising use of automated lipid analyzers, growing demand for preventive cardiovascular screening, expansion of home-based lipid testing kits, enhanced focus on early risk assessment.

The anticipated increase in cardiovascular and diabetic diseases is poised to drive the growth of the lipid panel testing market. Cardiovascular disease, a cluster of conditions affecting the heart and blood vessels, along with diabetes, a metabolic disorder impacting insulin production and leading to elevated blood sugar levels, collectively contribute to the demand for lipid panel testing. This diagnostic tool is crucial for identifying individuals at risk of developing cardiovascular diseases or those already affected. Additionally, it aids in monitoring treatment effectiveness, enabling healthcare providers to adjust treatment plans to attain target lipid levels and mitigate the risk of further ailments. For example, in September 2025, data from the American College of Cardiology, a United States-based nonprofit medical association, indicated that global deaths due to cardiovascular diseases reached approximately 19.2 million in 2023. Consequently, the escalating prevalence of cardiovascular and diabetic diseases is expected to propel the lipid panel testing market forward.

Leading companies operating in the lipid panel testing market are increasingly concentrating on the development of advanced diagnostic solutions, including lipoprotein(a)-based assays, to strengthen cardiovascular risk evaluation. An Lp(a)-based assay is a diagnostic test that measures lipoprotein(a) levels in the blood, helping clinicians identify individuals with a higher risk of cardiovascular disease and enabling more tailored treatment approaches. For instance, in May 2024, F. Hoffmann-La Roche AG, a Switzerland-based biotechnology and diagnostics company, introduced the Tina-quant Lp(a) RxDx assay after obtaining Breakthrough Device Designation from the United States Food and Drug Administration. This assay quantifies the number of Lp(a) particles per litre of blood, providing a standardized and clinically actionable biomarker for cardiovascular risk assessment. Designed for integration with Roche's existing serum work area systems and cobas platforms, the assay supports informed clinical decision-making related to Lp(a)-lowering therapies, enhances diagnostic precision, and encourages broader adoption of personalized lipid management approaches.

In July 2024, Hydreight Technologies Inc., a United States-based provider of at-home blood testing services, entered into a partnership with a national laboratory to broaden its testing offerings. Through this collaboration, Hydreight aims to expand access to a wider portfolio of laboratory tests across all fifty states in the United States, thereby improving patient convenience, accessibility, and turnaround times. The national laboratory involved is a United States-based provider of clinical laboratory testing services, specializing in comprehensive diagnostic testing and detailed reporting for both healthcare professionals and individual consumers.

Major companies operating in the lipid panel testing market are Abbott Laboratories, Beckman Coulter Inc., F. Hoffmann-La Roche Ltd., Randox Laboratories Ltd., Thermo Fisher Scientific Inc., PTS Diagnostics, Quest Diagnostics Incorporated, Alere Inc., Boston Heart Diagnostics Corporation, Eurofins Scientific SE, Spark Diagnostics Pvt Ltd., Everlywell Inc., Horiba ABX SAS, Siemens Healthcare GmbH, Nova Biomedical Corporation, Bio-Rad Laboratories Inc., Danaher Corporation, DiaSorin S.p.A., EKF Diagnostics Holdings plc, Ortho Clinical Diagnostics LLC

North America was the largest region in the lipid panel testing market in 2025. Asia-Pacific is expected to be the fastest growing region in the global lipid panel testing market during the forecast period. The regions covered in the lipid panel testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the lipid panel testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The lipid panel testing market consists of revenues earned by entities by providing high cholesterol testing and lipoprotein analysis. The market value includes the value of related goods sold by the service provider or included within the service offering. The lipid panel testing market also includes sales of cholesterol test kit, lipid profile analyzer, and cholesterol self-test kit which are used in providing testing services. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Lipid Panel Testing Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses lipid panel testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for lipid panel testing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The lipid panel testing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Product And Services: Devices; Kits; Services
  • 2) By Prescription Mode: Prescription-Based Testing; OTC-Based Testing
  • 3) By Application: Hyperlipidemia; Hypertriglyceridemia; Familial Hypercholesterolemia; Hypo-Lipoproteinemia; Tangier Disease; Atherosclerosis; Other Applications
  • 4) By End User: Hospital; Specialty Clinics And Physician Offices; Pathology Laboratories; Diagnostic Clinics; Reference Laboratories; Academic And Research Institutes; Other End-Users
  • Subsegments:
  • 1) By Devices: Automated Analyzers; Point-Of-Care Testing Devices; Spectrophotometers
  • 2) By Kits: Test Kits For Cholesterol; HDL And LDL Kits; Triglyceride Test Kits
  • 3) By Services: Laboratory Testing Services; Diagnostic Services; Health Screening Services
  • Companies Mentioned: Abbott Laboratories; Beckman Coulter Inc.; F. Hoffmann-La Roche Ltd.; Randox Laboratories Ltd.; Thermo Fisher Scientific Inc.; PTS Diagnostics; Quest Diagnostics Incorporated; Alere Inc.; Boston Heart Diagnostics Corporation; Eurofins Scientific SE; Spark Diagnostics Pvt Ltd.; Everlywell Inc.; Horiba ABX SAS; Siemens Healthcare GmbH; Nova Biomedical Corporation; Bio-Rad Laboratories Inc.; Danaher Corporation; DiaSorin S.p.A.; EKF Diagnostics Holdings plc; Ortho Clinical Diagnostics LLC
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Lipid Panel Testing Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Lipid Panel Testing Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Lipid Panel Testing Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Lipid Panel Testing Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Biotechnology, Genomics & Precision Medicine
    • 4.1.2 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.3 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
    • 4.1.4 Artificial Intelligence & Autonomous Intelligence
    • 4.1.5 Industry 4.0 & Intelligent Manufacturing
  • 4.2. Major Trends
    • 4.2.1 Increasing Adoption Of Point-Of-Care Lipid Testing
    • 4.2.2 Rising Use Of Automated Lipid Analyzers
    • 4.2.3 Growing Demand For Preventive Cardiovascular Screening
    • 4.2.4 Expansion Of Home-Based Lipid Testing Kits
    • 4.2.5 Enhanced Focus On Early Risk Assessment

5. Lipid Panel Testing Market Analysis Of End Use Industries

  • 5.1 Hospitals
  • 5.2 Diagnostic Clinics
  • 5.3 Pathology Laboratories
  • 5.4 Specialty Clinics And Physician Offices
  • 5.5 Ambulatory Surgical Centers

6. Lipid Panel Testing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Lipid Panel Testing Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Lipid Panel Testing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Lipid Panel Testing Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Lipid Panel Testing Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Lipid Panel Testing Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Lipid Panel Testing Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Lipid Panel Testing Market Segmentation

  • 9.1. Global Lipid Panel Testing Market, Segmentation By Product And Services, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Devices, Kits, Services
  • 9.2. Global Lipid Panel Testing Market, Segmentation By Prescription Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Prescription-Based Testing, OTC-Based Testing
  • 9.3. Global Lipid Panel Testing Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Hyperlipidemia, Hypertriglyceridemia, Familial Hypercholesterolemia, Hypo-Lipoproteinemia, Tangier Disease, Atherosclerosis, Other Applications
  • 9.4. Global Lipid Panel Testing Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Hospital, Specialty Clinics And Physician Offices, Pathology Laboratories, Diagnostic Clinics, Reference Laboratories, Academic And Research Institutes, Other End-Users
  • 9.5. Global Lipid Panel Testing Market, Sub-Segmentation Of Devices, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Automated Analyzers, Point-Of-Care Testing Devices, Spectrophotometers
  • 9.6. Global Lipid Panel Testing Market, Sub-Segmentation Of Kits, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Test Kits For Cholesterol, HDL And LDL Kits, Triglyceride Test Kits
  • 9.7. Global Lipid Panel Testing Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Laboratory Testing Services, Diagnostic Services, Health Screening Services

10. Lipid Panel Testing Market Regional And Country Analysis

  • 10.1. Global Lipid Panel Testing Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Lipid Panel Testing Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Lipid Panel Testing Market

  • 11.1. Asia-Pacific Lipid Panel Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Lipid Panel Testing Market, Segmentation By Product And Services, Segmentation By Prescription Mode, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Lipid Panel Testing Market

  • 12.1. China Lipid Panel Testing Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Lipid Panel Testing Market, Segmentation By Product And Services, Segmentation By Prescription Mode, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Lipid Panel Testing Market

  • 13.1. India Lipid Panel Testing Market, Segmentation By Product And Services, Segmentation By Prescription Mode, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Lipid Panel Testing Market

  • 14.1. Japan Lipid Panel Testing Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Lipid Panel Testing Market, Segmentation By Product And Services, Segmentation By Prescription Mode, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Lipid Panel Testing Market

  • 15.1. Australia Lipid Panel Testing Market, Segmentation By Product And Services, Segmentation By Prescription Mode, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Lipid Panel Testing Market

  • 16.1. Indonesia Lipid Panel Testing Market, Segmentation By Product And Services, Segmentation By Prescription Mode, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Lipid Panel Testing Market

  • 17.1. South Korea Lipid Panel Testing Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Lipid Panel Testing Market, Segmentation By Product And Services, Segmentation By Prescription Mode, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Lipid Panel Testing Market

  • 18.1. Taiwan Lipid Panel Testing Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Lipid Panel Testing Market, Segmentation By Product And Services, Segmentation By Prescription Mode, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Lipid Panel Testing Market

  • 19.1. South East Asia Lipid Panel Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Lipid Panel Testing Market, Segmentation By Product And Services, Segmentation By Prescription Mode, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Lipid Panel Testing Market

  • 20.1. Western Europe Lipid Panel Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Lipid Panel Testing Market, Segmentation By Product And Services, Segmentation By Prescription Mode, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Lipid Panel Testing Market

  • 21.1. UK Lipid Panel Testing Market, Segmentation By Product And Services, Segmentation By Prescription Mode, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Lipid Panel Testing Market

  • 22.1. Germany Lipid Panel Testing Market, Segmentation By Product And Services, Segmentation By Prescription Mode, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Lipid Panel Testing Market

  • 23.1. France Lipid Panel Testing Market, Segmentation By Product And Services, Segmentation By Prescription Mode, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Lipid Panel Testing Market

  • 24.1. Italy Lipid Panel Testing Market, Segmentation By Product And Services, Segmentation By Prescription Mode, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Lipid Panel Testing Market

  • 25.1. Spain Lipid Panel Testing Market, Segmentation By Product And Services, Segmentation By Prescription Mode, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Lipid Panel Testing Market

  • 26.1. Eastern Europe Lipid Panel Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Lipid Panel Testing Market, Segmentation By Product And Services, Segmentation By Prescription Mode, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Lipid Panel Testing Market

  • 27.1. Russia Lipid Panel Testing Market, Segmentation By Product And Services, Segmentation By Prescription Mode, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Lipid Panel Testing Market

  • 28.1. North America Lipid Panel Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Lipid Panel Testing Market, Segmentation By Product And Services, Segmentation By Prescription Mode, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Lipid Panel Testing Market

  • 29.1. USA Lipid Panel Testing Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Lipid Panel Testing Market, Segmentation By Product And Services, Segmentation By Prescription Mode, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Lipid Panel Testing Market

  • 30.1. Canada Lipid Panel Testing Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Lipid Panel Testing Market, Segmentation By Product And Services, Segmentation By Prescription Mode, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Lipid Panel Testing Market

  • 31.1. South America Lipid Panel Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Lipid Panel Testing Market, Segmentation By Product And Services, Segmentation By Prescription Mode, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Lipid Panel Testing Market

  • 32.1. Brazil Lipid Panel Testing Market, Segmentation By Product And Services, Segmentation By Prescription Mode, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Lipid Panel Testing Market

  • 33.1. Middle East Lipid Panel Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Lipid Panel Testing Market, Segmentation By Product And Services, Segmentation By Prescription Mode, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Lipid Panel Testing Market

  • 34.1. Africa Lipid Panel Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Lipid Panel Testing Market, Segmentation By Product And Services, Segmentation By Prescription Mode, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Lipid Panel Testing Market Regulatory and Investment Landscape

36. Lipid Panel Testing Market Competitive Landscape And Company Profiles

  • 36.1. Lipid Panel Testing Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Lipid Panel Testing Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Lipid Panel Testing Market Company Profiles
    • 36.3.1. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Beckman Coulter Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. Randox Laboratories Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis

37. Lipid Panel Testing Market Other Major And Innovative Companies

  • PTS Diagnostics, Quest Diagnostics Incorporated, Alere Inc., Boston Heart Diagnostics Corporation, Eurofins Scientific SE, Spark Diagnostics Pvt Ltd., Everlywell Inc., Horiba ABX SAS, Siemens Healthcare GmbH, Nova Biomedical Corporation, Bio-Rad Laboratories Inc., Danaher Corporation, DiaSorin S.p.A., EKF Diagnostics Holdings plc, Ortho Clinical Diagnostics LLC

38. Global Lipid Panel Testing Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Lipid Panel Testing Market

40. Lipid Panel Testing Market High Potential Countries, Segments and Strategies

  • 40.1 Lipid Panel Testing Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 Lipid Panel Testing Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 Lipid Panel Testing Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer